|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2001-7-4
|
|
pubmed:abstractText |
Our goal was to provide health-care providers, patients, and the general public with an assessment of currently available data regarding the use of adjuvant therapy for breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
pubmed-author:AxelsonJ AJA,
pubmed-author:CosteFF,
pubmed-author:CrowleyJJ,
pubmed-author:CurranW JWJJr,
pubmed-author:DeshlerAA,
pubmed-author:EifelPP,
pubmed-author:FultonSS,
pubmed-author:HendricksC BCB,
pubmed-author:KemenyMM,
pubmed-author:KornblithA BAB,
pubmed-author:LouisT ATA,
pubmed-author:MarkmanMM,
pubmed-author:MayerRR,
pubmed-author:RoterDD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
979-89
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11438563-Adjuvants, Pharmaceutic,
pubmed-meshheading:11438563-Aged,
pubmed-meshheading:11438563-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11438563-Breast Neoplasms,
pubmed-meshheading:11438563-Clinical Trials as Topic,
pubmed-meshheading:11438563-Female,
pubmed-meshheading:11438563-Humans,
pubmed-meshheading:11438563-MEDLINE,
pubmed-meshheading:11438563-Middle Aged
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
|
|
pubmed:affiliation |
The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
|
|
pubmed:publicationType |
Journal Article,
Review,
Consensus Development Conference
|
